NCT02685683

Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease

Study terminated by Sponsor following a recommendation from external DMC to terminate the ongoing Phase 3 CD studies; there were no new emergent safety findings